tiprankstipranks
Trending News
More News >
LifeMD (LFMD)
NASDAQ:LFMD
US Market

LifeMD (LFMD) Earnings Dates, Call Summary & Reports

Compare
584 Followers

Earnings Data

Report Date
Aug 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.02
Last Year’s EPS
-0.19
Same Quarter Last Year
Based on 8 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 06, 2025
|
% Change Since: 10.18%
|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Positive
The earnings call for LifeMD reflects a positive sentiment, characterized by strong revenue growth in the Telehealth segment, strategic collaborations, and expansion into new verticals. The company achieved positive GAAP net income for the first time and raised its financial guidance for the year. Despite minor challenges such as a decline in WorkSimpli subscribers and a decrease in gross margin, the company's highlights significantly outweigh the lowlights.
Company Guidance
During the recent earnings call, LifeMD provided an optimistic update on its financial guidance for 2025, fueled by the strong performance of its Telehealth business. The company raised its total revenue projection to a range between $268 million and $275 million, with Telehealth revenue expected between $208 million and $213 million. Additionally, LifeMD adjusted its consolidated adjusted EBITDA guidance to fall between $31 million and $33 million, with Telehealth adjusted EBITDA anticipated to be at least $21 million. This upward revision reflects the significant 49% increase in total revenues to $65.7 million for the first quarter, bolstered by a 70% year-over-year growth in Telehealth revenue. The company also highlighted its successful strategic initiatives, including collaborations with GLP-1 manufacturers and the expansion into women's and behavioral health.
Core Telehealth Revenue Growth
Core Telehealth business experienced a 70% year-over-year revenue growth, driven by the weight management program, with adjusted EBITDA reaching $5.3 million, a significant improvement from a loss of $1.3 million in the previous year.
Strategic Expansion and Collaborations
LifeMD has established strategic collaborations with LillyDirect and NovoCare to improve access to GLP-1 medications for weight management patients, enhancing its competitive position in virtual obesity care.
Positive GAAP Net Income
LifeMD reported a GAAP net income of $608,000 for the first quarter, marking the first quarter with positive GAAP net income, compared to a loss of $7.5 million in the previous year.
Growth in Subscriber Base
Telehealth subscriber base increased by 22% year-over-year to over 290,000, indicating strong customer retention and acquisition.
RexMD Brand Performance
The RexMD brand continues to perform well with growth in revenue and active patient count, especially in new verticals like hormone replacement therapy.
Expansion into New Verticals
LifeMD is entering high-growth verticals such as women’s health and behavioral health, which are expected to contribute to revenue diversification and long-term profitability.
Increased Financial Guidance
Due to the strong performance of the Telehealth business, LifeMD raised its financial guidance for 2025 with expected total revenues between $268 million to $275 million.
---

LifeMD (LFMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LFMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 07, 2025
2025 (Q2)
-0.02 / -
-0.19
May 06, 2025
2025 (Q1)
-0.05 / 0.01
-0.19105.26% (+0.20)
Mar 10, 2025
2024 (Q4)
-0.05 / -0.02
-0.1283.33% (+0.10)
Nov 07, 2024
2024 (Q3)
-0.12 / -0.14
-0.230.00% (+0.06)
Aug 07, 2024
2024 (Q2)
-0.14 / -0.19
0.05-480.00% (-0.24)
May 08, 2024
2024 (Q1)
-0.15 / -0.19
0.06-416.67% (-0.25)
Mar 11, 2024
2023 (Q4)
-0.14 / -0.12
-0.470.00% (+0.28)
Nov 08, 2023
2023 (Q3)
-0.09 / -0.20
-0.03-566.67% (-0.17)
Aug 09, 2023
2023 (Q2)
-0.10 / 0.05
-0.22122.73% (+0.27)
May 12, 2023
2023 (Q1)
-0.16 / 0.06
-0.25124.00% (+0.31)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

LFMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 06, 2025
$7.76$8.01+3.22%
Mar 10, 2025
$4.27$5.58+30.68%
Nov 07, 2024
$5.13$5.85+14.04%
Aug 07, 2024
$5.37$5.22-2.79%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does LifeMD (LFMD) report earnings?
LifeMD (LFMD) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
    What is LifeMD (LFMD) earnings time?
    LifeMD (LFMD) earnings time is at Aug 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LFMD EPS forecast?
          LFMD EPS forecast for the fiscal quarter 2025 (Q2) is -0.02.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis